Philip Morris lifts bid for UK’s Vectura to 165 pence per share

imageStock Markets14 hours ago (Aug 08, 2021 15:05)

© Reuters. FILE PHOTO: Undated handout image of Vectura’s AKITA JET inhalation system provided to Reuters July 9, 2021. Vectura/Handout via REUTERS

(Reuters) -Philip Morris has raised its bid for British drugmaker Vectura to 165 pence ($2.29) per share, the tobacco company said on Sunday.

“The PMI (Philip Morris (NYSE:PM) International) increased offer values the entire issued and to be issued ordinary share capital of Vectura at approximately 1.02 billion pounds ($1.41 billion),” it said in an emailed statement to Reuters.

The latest offer represents a premium of approximately 10 pence per share to a rival offer of 155 pence a share by U.S.-based Carlyle Group (NASDAQ:CG) announced on Friday.

Carlyle offered to buy Vectura for about 958 million pounds ($1.3 billion).

Vectura, which makes respiratory treatments, had said on Friday that it was backing Carlyle’s offer and withdrawing its recommendation for Philip Morris’ proposal, adding that it might be better positioned under Carlyle’s ownership.

Vectura did not immediately respond to a Reuters request for comment on Sunday.

“PMI intends to operate Vectura as an autonomous business unit that will form the backbone of its inhaled therapeutics business,” Philip Morris said in the statement.

The previously agreed deal with Philip Morris came as big tobacco companies are trying to alter their image after years of negative press and lawsuits for marketing and selling health-harming cigarettes, which health advocates and experts say continues to be a leading cause of preventable deaths worldwide.

($1 = 0.7209 pounds)

Philip Morris lifts bid for UK’s Vectura to 165 pence per share

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


Please enter your comment!
Please enter your name here